Zobrazeno 1 - 4
of 4
pro vyhledávání: '"K. C. M. van der Elst"'
Autor:
T. Bognàr, J. S. Kingma, E. H. Smeijsters, K. C. M. van der Elst, C. T. M. de Kanter, C. A. Lindemans, A. C. G. Egberts, I. H. Bartelink, A. Lalmohamed
Publikováno v:
Bone Marrow Transplantation. Nature Publishing Group
Bognàr, T, Kingma, J S, Smeijsters, E H, van der Elst, K C M, de Kanter, C T M, Lindemans, C A, Egberts, A C G, Bartelink, I H & Lalmohamed, A 2023, ' Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation : a single day versus a multiday therapeutic drug monitoring regimen ', Bone Marrow Transplantation, vol. 58, no. 7, pp. 762-768 . https://doi.org/10.1038/s41409-023-01971-z
Bognàr, T, Kingma, J S, Smeijsters, E H, van der Elst, K C M, de Kanter, C T M, Lindemans, C A, Egberts, A C G, Bartelink, I H & Lalmohamed, A 2023, ' Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation : a single day versus a multiday therapeutic drug monitoring regimen ', Bone Marrow Transplantation, vol. 58, no. 7, pp. 762-768 . https://doi.org/10.1038/s41409-023-01971-z
Busulfan exposure has previously been linked to clinical outcomes, hence the need for therapeutic drug monitoring (TDM). Study objective was to evaluate the effect of day 1 TDM-guided dosing (regimen d1) versus days 1 + 2 TDM-guided dosing (regimen d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2f300066d93d1829bb3b197638f3dd
https://research.vumc.nl/en/publications/5527bccd-ce9f-4256-a4bf-93e1a93712dc
https://research.vumc.nl/en/publications/5527bccd-ce9f-4256-a4bf-93e1a93712dc
Autor:
Bart G. J. Dekkers, Deborah Marriott, Andrew J. McLachlan, K. C. M. van der Elst, Jan-Willem C. Alffenaar, J M Boonstra, F F Doukas, Anette Veringa
Publikováno v:
Drugs & Aging
Drugs & Aging, 35(9), 781-789. ADIS INT LTD
Drugs & Aging, 35(9), 781-789. ADIS INT LTD
Candida infections in the elderly are an important and expanding clinical problem, with significantly higher mortality in this group than in younger patients. The increasing problem of invasive Candida infections may be related to higher prevalence o
Autor:
Anette Veringa, K. C. M. van der Elst, Greetje A. Kampinga, Daan J Touw, Roger J. M. Brüggemann, Jos G. W. Kosterink, Jan-Willem C. Alffenaar, Jan G. Zijlstra, Erwin M Jongedijk, J M Boonstra, T S van der Werf, Remco A. Koster
Publikováno v:
Antimicrobial Agents and Chemotherapy, 61, 12, pp. e01398-17-e01398-17
Antimicrobial Agents and Chemotherapy, 61, e01398-17-e01398-17
Antimicrobial Agents and Chemotherapy, 61(12):e01398-17. AMER SOC MICROBIOLOGY
Antimicrobial Agents and Chemotherapy, 61, e01398-17-e01398-17
Antimicrobial Agents and Chemotherapy, 61(12):e01398-17. AMER SOC MICROBIOLOGY
The estimated attributable mortality rate for invasive candidiasis (IC) in the intensive care unit (ICU) setting varies from 30 to 40%. Physiological changes in critically ill patients may affect the distribution and elimination of micafungin, and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d67808d5f93f3ba619ce536e0eedcab
https://europepmc.org/articles/PMC5700342/
https://europepmc.org/articles/PMC5700342/
Autor:
Michael G. G. Rodgers, K. C. M. van der Elst, Jan-Willem C. Alffenaar, Roger J. M. Brüggemann
Publikováno v:
Transplant Infectious Disease, 14, 4, pp. 440-3
Transplant Infectious Disease, 14(4), 440-443. Wiley-Blackwell
Transplant Infectious Disease, 14, 440-3
Transplant Infectious Disease, 14(4), 440-443. Wiley-Blackwell
Transplant Infectious Disease, 14, 440-3
Item does not contain fulltext The currently recommended dosage regimen of caspofungin (50 mg/day) was developed for patients with invasive candidiasis. With invasive aspergillosis, successful outcomes occur in less than half the patients. We evaluat